{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:21:44Z","timestamp":1784240504981,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04598-y","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T10:16:00Z","timestamp":1769163360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of high-density lipoprotein cholesterol lipid with peritoneal dialysis related peritonitis"],"prefix":"10.1186","volume":"27","author":[{"given":"Jinsheng","family":"Mai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"2","key":"4598_CR1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li PK, Chow KM, Van de Luijtgaarden MW, et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol. 2017;13(2):90\u2013103. https:\/\/doi.org\/10.1038\/nrneph.2016.181.","journal-title":"Nat Rev Nephrol"},{"key":"4598_CR2","doi-asserted-by":"publisher","unstructured":"Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment [published correction appears in Perit Dial Int. 2023 May;43(3): 279. 10.1177\/08968608231166870]. [published correction appears in Perit Dial Int. 2024 May;44(3): 223. 10.1177\/08968608241251453]. Perit Dial Int. 2022;42(2):110\u201353. https:\/\/doi.org\/10.1177\/08968608221080586.","DOI":"10.1177\/08968608221080586"},{"issue":"4","key":"4598_CR3","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1681\/ASN.2006091006","volume":"18","author":"BC Kwan","year":"2007","unstructured":"Kwan BC, Kronenberg F, Beddhu S, Cheung AK. Lipoprotein metabolism and lipid management in chronic kidney disease. J Am Soc Nephrol. 2007;18(4):1246\u201361. https:\/\/doi.org\/10.1681\/ASN.2006091006.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4598_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0272-6386(12)80030-8","volume":"21","author":"PO Attman","year":"1993","unstructured":"Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis. 1993;21(6):573\u201392. https:\/\/doi.org\/10.1016\/s0272-6386(12)80030-8.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4598_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tem.2010.10.001","volume":"22","author":"SM Gordon","year":"2011","unstructured":"Gordon SM, Hofmann S, Askew DS, Davidson WS. High density lipoprotein: it\u2019s not just about lipid transport anymore. Trends Endocrinol Metab. 2011;22(1):9\u201315. https:\/\/doi.org\/10.1016\/j.tem.2010.10.001.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"4598_CR6","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.tem.2020.01.003","volume":"31","author":"LL Blauw","year":"2020","unstructured":"Blauw LL, Wang Y, Willems van Dijk K, Rensen PCN. A novel role for cetp as immunological gatekeeper: raising HDL to cure sepsis? Trends Endocrinol Metab. 2020;31(5):334\u201343. https:\/\/doi.org\/10.1016\/j.tem.2020.01.003.","journal-title":"Trends Endocrinol Metab"},{"key":"4598_CR7","doi-asserted-by":"publisher","first-page":"108684","DOI":"10.1016\/j.pharmthera.2024.108684","volume":"260","author":"A Rani","year":"2024","unstructured":"Rani A, Stadler JT, Marsche G. HDL-based therapeutics: a promising frontier in combating viral and bacterial infections. Pharmacol Ther. 2024;260:108684. https:\/\/doi.org\/10.1016\/j.pharmthera.2024.108684.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"4598_CR8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim MS, Memon RA, et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004;45(7):1169\u201396. https:\/\/doi.org\/10.1194\/jlr.R300019-JLR200.","journal-title":"J Lipid Res"},{"key":"4598_CR9","doi-asserted-by":"publisher","unstructured":"Tanaka S, Couret D, Tran-Dinh A, et al. High-density lipoproteins during sepsis: from bench to bedside. Crit Care. 2020;24(1):134. https:\/\/doi.org\/10.1186\/s13054-020-02860-3. Published 2020 Apr 7.","DOI":"10.1186\/s13054-020-02860-3"},{"issue":"1","key":"4598_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13098-022-00832-x","volume":"14","author":"R Zhang","year":"2022","unstructured":"Zhang R, Zhang X, Tang X, et al. The association between diabetes coexisting with low levels of high-density lipoprotein cholesterol and peritoneal dialysis-related peritonitis. Diabetol Metab Syndr. 2022;14(1):60. https:\/\/doi.org\/10.1186\/s13098-022-00832-x.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"4598_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cjca.2019.08.028","volume":"36","author":"H Ye","year":"2020","unstructured":"Ye H, Wu H, Peng Y, et al. Peritonitis affects the relationship between low-density lipoprotein cholesterol and cardiovascular events in peritoneal dialysis patients. Can J Cardiol. 2020;36(1):92\u201399. https:\/\/doi.org\/10.1016\/j.cjca.2019.08.028.","journal-title":"Can J Cardiol"},{"issue":"3","key":"4598_CR12","doi-asserted-by":"publisher","first-page":"M139","DOI":"10.1097\/00002480-199207000-00004","volume":"38","author":"KD Nolph","year":"1992","unstructured":"Nolph KD, Moore HL, Twardowski ZJ, et al. Cross-sectional assessment ofweekly urea and creatinine clearances in patients on continuous ambulatory peritoneal dialysis. Asaio J. 1992;38(3):M139\u201342. https:\/\/doi.org\/10.1097\/00002480-199207000-00004.","journal-title":"Asaio J"},{"issue":"3","key":"4598_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/089686088700700306","volume":"7","author":"TZ J","year":"1987","unstructured":"Twardowski ZJ, Nolph KO, Khanna R, et al. Peritoneal equilibration test [J]. Perit Dialysis Int: J Int Soc Perit Dialysis. 1987;7(3):138\u201347. https:\/\/doi.org\/10.1177\/089686088700700306.","journal-title":"Perit Dialysis Int: J Int Soc Perit Dialysis"},{"issue":"19","key":"4598_CR14","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National cholesterol Education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397. https:\/\/doi.org\/10.1001\/jama.285.19.2486.","journal-title":"JAMA"},{"issue":"2","key":"4598_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3747\/pdi.2016.00120","volume":"37","author":"CC Szeto","year":"2017","unstructured":"Szeto CC, Li PK, Johnson DW, et al. ISPD catheter-related infection recommendations: 2017 update. Perit Dial Int. 2017;37(2):141\u201354. https:\/\/doi.org\/10.3747\/pdi.2016.00120.","journal-title":"Perit Dial Int"},{"issue":"2","key":"4598_CR16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0022-2275(20)33363-0","volume":"40","author":"C Grunfeld","year":"1999","unstructured":"Grunfeld C, Marshall M, Shigenaga JK, Moser AH, Tobias P, Feingold KR. Lipoproteins inhibit macrophage activation by lipoteichoic acid. J Lipid Res. 1999;40(2):245\u201352.","journal-title":"J Lipid Res"},{"issue":"1","key":"4598_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00134-006-0432-y","volume":"33","author":"O Murch","year":"2007","unstructured":"Murch O, Collin M, Hinds CJ, Thiemermann C. Lipoproteins in inflammation and sepsis. I. Basic science. Intensive Care Med. 2007;33(1):13\u201324. https:\/\/doi.org\/10.1007\/s00134-006-0432-y.","journal-title":"Intensive Care Med"},{"issue":"2","key":"4598_CR18","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00109-010-0690-6","volume":"89","author":"S Van Linthout","year":"2011","unstructured":"Van Linthout S, Spillmann F, Graiani G, et al. Down-regulation of endothelial TLR4 signalling after apo A-I gene transfer contributes to improved survival in an experimental model of lipopolysaccharide-induced inflammation. J Mol Med (Berl). 2011;89(2):151\u201360. https:\/\/doi.org\/10.1007\/s00109-010-0690-6.","journal-title":"J Mol Med (Berl)"},{"issue":"6","key":"4598_CR19","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.4049\/jimmunol.1600702","volume":"197","author":"Z Yao","year":"2016","unstructured":"Yao Z, Mates JM, Cheplowitz AM, et al. Blood-borne lipopolysaccharide is rapidly eliminated by liver sinusoidal endothelial cells via high-density lipoprotein. J Immunol. 2016;197(6):2390\u201399. https:\/\/doi.org\/10.4049\/jimmunol.1600702.","journal-title":"J Immunol"},{"issue":"1","key":"4598_CR20","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1172\/JCI31539","volume":"118","author":"L Cai","year":"2008","unstructured":"Cai L, Ji A, de Beer Fc, Tannock LR, van der Westhuyzen DR. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J Clin Invest. 2008;118(1):364\u201375. https:\/\/doi.org\/10.1172\/JCI31539.","journal-title":"J Clin Invest"},{"issue":"1\u20133","key":"4598_CR21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ejphar.2008.06.047","volume":"590","author":"Y Li","year":"2008","unstructured":"Li Y, Dong JB, Wu MP. Human ApoA-I overexpression diminishes LPS-induced systemic inflammation and multiple organ damage in mice. Eur J Pharmacol. 2008;590(1\u20133):417\u201322. https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.047.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4598_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cmet.2016.10.013","volume":"25","author":"van der Vorst Epc","year":"2017","unstructured":"van der Vorst EPC, Theodorou K, Wu Y, et al. High-density lipoproteins exert pro-inflammatory effects on macrophages via passive cholesterol depletion and PKC-NF-\u03baB\/STAT1-IRF1 signaling. Cell Metab. 2017;25(1):197\u2013207. https:\/\/doi.org\/10.1016\/j.cmet.2016.10.013.","journal-title":"Cell Metab"},{"key":"4598_CR23","doi-asserted-by":"publisher","first-page":"1106339","DOI":"10.3389\/fphar.2023.1106339","volume":"14","author":"J Lu","year":"2023","unstructured":"Lu J, Gao J, Sun J, et al. Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation. Front Pharmacol. 2023;14:1106339. https:\/\/doi.org\/10.3389\/fphar.2023.1106339.","journal-title":"Front Pharmacol"},{"issue":"10","key":"4598_CR24","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.3390\/biomedicines12102377","volume":"12","author":"N Stepanova","year":"2024","unstructured":"Stepanova N. Dyslipidemia in peritoneal dialysis: implications for peritoneal membrane function and patient outcomes. Biomedicines. 2024;12(10):2377. https:\/\/doi.org\/10.3390\/biomedicines12102377.","journal-title":"Biomedicines"},{"key":"4598_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/eci.70099","author":"M Nguyen","year":"2025","unstructured":"Nguyen M, Alvarez M, Berthoud V, et al. High-density lipoproteins alleviate the endotoxin burden in patients with peritonitis and sepsis: the lips study. Eur J Clin Invest. 2025, July, 19. https:\/\/doi.org\/10.1111\/eci.70099.","journal-title":"Eur J Clin Invest"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04598-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04598-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T10:55:29Z","timestamp":1771325729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-025-04598-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4598"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04598-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Committee of Nanfang Hospital, Guangzhou, China (ethics number NFEC-2010-78). Informed consent was waived for this retrospective study by the institutional review board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors approved the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}